Inhibition of wild-type and mutant human immunodeficiency virus type 1 proteases by GW0385 and other arylsulfonamides

被引:16
作者
Hanlon, MH [1 ]
Porter, DJT [1 ]
Furfine, ES [1 ]
Spaltenstein, A [1 ]
Carter, HL [1 ]
Danger, D [1 ]
Shu, AYL [1 ]
Kaldor, IW [1 ]
Miller, JF [1 ]
Samano, VA [1 ]
机构
[1] GlaxoSmithKline, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1021/bi0488799
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The arylsulfonamide derivatives described herein were such potent inhibitors of human immunodeficiency virus type 1 (HIV-1) protease (enzyme, E) that values for the inhibition constants (K-i) could not be determined by conventional steady-state kinetic techniques (i.e., the minimal enzyme concentration usable for the activity assay was much greater than the value of the dissociation constant). Consequently, two alternative methods were developed for estimation of Ki values. The first method employed kinetic determinations of values for k(1), and k(-1), from which Ki was determined (k(-1)/k(1)). The second method was a competitive displacement assay used to determine binding affinities of other inhibitors relative to that of GW0385. In these assays, the inhibitor of unknown affinity was used to displace [H-3]GW0385 from E.[H-3]GW0385. From the concentration of E.[H-3]GW0385 at equilibrium, the concentrations of enzyme-bound and free inhibitors were calculated, and the ratio of the Ki value of the unknown to that of GW0385 was determined (Ki,unknown/Ki,GW0385). The values of k, were calculated from data in which changes in the intrinsic protein fluorescence of the enzyme associated with inhibitor binding were directly or indirectly monitored. In the case of saquinavir, the fluorescence changes associated with complex formation were large enough to monitor directly. The value of k, for saquinavir was 62 +/- 2 muM(-1) s(-1). In the case of GW0385, the fluorescence changes associated with complex formation were too small to monitor directly. Consequently, the value of k, was estimated from a competition experiment in which the effect of GW0385 on the binding of E to saquinavir was determined. The value of k, for GW0385 was estimated from these experiments to be 137 +/- 4 muM(-1) s(-1). Because E.[H-3]GW0385 was stable in the standard buffer at room temperature for greater than 33 days, the value of the first-order rate constant for dissociation of E.[H-3]GWO385 (k(-1)) could be estimated from the time-course for exchange of E.[H-3]GW0385 with excess unlabeled GW0385. The value of k(-1) calculated from these data was (2.1 +/- 0.1) x 10(-6) S-1 (t(1/2) = 91 h). The K-i value of wild-type HIV-1 protease for GW0385, calculated from these values for k(1), and k(-1), was 15 +/- 1 fM. Three multidrug resistant enzymes had Ki values for GW0385 that were less than 5 pM.
引用
收藏
页码:14500 / 14507
页数:8
相关论文
共 27 条
[1]   Resistance to human immunodeficiency virus type 1 protease inhibitors [J].
Boden, D ;
Markowitz, M .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2775-2783
[2]   STUDY OF STRONG TO ULTRATIGHT PROTEIN INTERACTIONS USING DIFFERENTIAL SCANNING CALORIMETRY [J].
BRANDTS, JF ;
LIN, LN .
BIOCHEMISTRY, 1990, 29 (29) :6927-6940
[3]   IN-VIVO EMERGENCE OF HIV-1 VARIANTS RESISTANT TO MULTIPLE PROTEASE INHIBITORS [J].
CONDRA, JH ;
SCHLEIF, WA ;
BLAHY, OM ;
GABRYELSKI, LJ ;
GRAHAM, DJ ;
QUINTERO, JC ;
RHODES, A ;
ROBBINS, HL ;
ROTH, E ;
SHIVAPRAKASH, M ;
TITUS, D ;
YANG, T ;
TEPPLER, H ;
SQUIRES, KE ;
DEUTSCH, PJ ;
EMINI, EA .
NATURE, 1995, 374 (6522) :569-571
[4]   Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease [J].
Dauber, DS ;
Ziermann, R ;
Parkin, N ;
Maly, DJ ;
Mahrus, S ;
Harris, JL ;
Ellman, JA ;
Petropoulos, C ;
Craik, CS .
JOURNAL OF VIROLOGY, 2002, 76 (03) :1359-1368
[5]   Thermodynamics of ligand binding to acyl-coenzyme a binding protein studied by titration calorimetry [J].
Faergeman, NJ ;
Sigurskjold, BW ;
Kragelund, BB ;
Andersen, KV ;
Knudsen, J .
BIOCHEMISTRY, 1996, 35 (45) :14118-14126
[6]   2-STEP BINDING MECHANISM FOR HIV PROTEASE INHIBITORS [J].
FURFINE, ES ;
DSOUZA, E ;
INGOLD, KJ ;
LEBAN, JJ ;
SPECTOR, T ;
PORTER, DJT .
BIOCHEMISTRY, 1992, 31 (34) :7886-7891
[7]  
FURFINE ES, 2000, HANDB EXP PHARM, V140, P49
[8]   Analysis of the pH-dependencies of the association and dissociation kinetics of HIV-1 protease inhibitors [J].
Gossas, T ;
Danielson, UH .
JOURNAL OF MOLECULAR RECOGNITION, 2003, 16 (04) :203-212
[9]  
HALE MR, 2000, Patent No. 2000047551
[10]   Program DYNAFIT for the analysis of enzyme kinetic data: Application to HIV proteinase [J].
Kuzmic, P .
ANALYTICAL BIOCHEMISTRY, 1996, 237 (02) :260-273